Form 4: TD SYNNEX Director Sells Shares Under 10b5-1 Plan
Insider Transaction Report
TD SYNNEX Director Merline Saintil reported the sale of 336 common shares for $155.79 each, executed under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Merline Saintil, a Director of TD SYNNEX Corp (SNX), reported the sale of 336 shares of common stock.
- The transaction occurred on November 3, 2025, at a price of $155.79 per share.
- Following this transaction, Saintil beneficially owns 7,330 shares of common stock.
- The sale was conducted pursuant to a Rule 10b5-1 trading plan, which was adopted by Saintil on August 2, 2025.
- A Power of Attorney, dated June 18, 2025, authorizes specific individuals to execute and file SEC Forms 3, 4, and 5 on Saintil's behalf.
Sentiment
Score: 5
Explanation: The sale of shares by a director, while a disposition, was conducted under a pre-arranged Rule 10b5-1 trading plan, suggesting it was not based on new, non-public information. This makes the transaction largely neutral in terms of immediate sentiment, though some investors may still view any insider selling with slight caution.
Positives
- The sale was executed under a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction rather than a reaction to recent non-public information.
Negatives
- A director's sale of shares, even if pre-planned, can sometimes be perceived negatively by investors as it reduces insider ownership.
Risks
- Potential for negative investor sentiment if the market misinterprets the insider sale as a lack of confidence, despite the 10b5-1 plan.
Future Outlook
N/A
Industry Context
N/A
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Delegation of Authority | Merline Saintil, a Director, granted a Power of Attorney to David Vetter, Wayne Hanewicz, Cheryl Grant, and Maribeth Bautista to execute and file Forms 3, 4, and 5 with the SEC on her behalf. This includes obtaining EDGAR credentials and managing her EDGAR account. | 2025-06-18 | Streamlines the process for insider transaction reporting, ensuring timely and compliant filings for the director. |
Stakeholder Impact
- Shareholders: May observe a minor impact on sentiment due to a director's share sale, though mitigated by the 10b5-1 plan.
Next Steps
- Merline Saintil will continue to be subject to Section 16 filing requirements as long as she remains a director or officer of TD SYNNEX Corporation.
- The appointed attorneys-in-fact will continue to execute and file Forms 3, 4, and 5 on Saintil's behalf as needed.
Key Dates
| Date | Description |
|---|---|
| 2025-06-18 | Date Power of Attorney was executed by Merline Saintil. |
| 2025-08-02 | Date Merline Saintil adopted the Rule 10b5-1 trading plan. |
| 2025-11-03 | Date of the reported transaction (sale of common stock). |
| 2025-11-04 | Date the Form 4 was signed and filed. |
Keywords
TD SYNNEX, SNX, Merline Saintil, Form 4, insider trading, stock sale, 10b5-1 plan, director, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.